European Neuropsychopharmacology
Volume 20, Issue 5 , Pages 336-345, May 2010

Region- and phase-dependent effects of 5-HT1A and 5-HT2C receptor activation on adult neurogenesis

IC2N, IBDML, UMR 6216, CNRS-Université de la Mediterranée, Luminy Scientific Campus; Marseille, France

Received 23 June 2009; received in revised form 26 October 2009; accepted 18 November 2009. published online 18 December 2009.

Abstract 

Adult neurogenesis and serotoninergic transmission are associated to mood disorders and their treatments. The present study focused on the effects of chronic activation of 5-HT1A and 5-HT2C receptors on newborn cell survival in the dentate gyrus (DG) and olfactory bulb (OB), and examined whether potential neurogenic zones as the prefrontal cortex (PFC) and striatum (ST) are reactive to these treatments. Administration of 8-OH-DPAT, but not RO600,175 increases neurogenesis and survival of late differentiating cells (15–21days) in the DG. Both 8-OH-DPAT and RO600,175 increase neurogenesis in the OB, but only 8-OH-DPAT affected cell survival, inducing a parallel decrease in the number of BrdU cells in the OB and increase in the SVZ, which suggests an impaired migration. In the PFC and ST, 8-OH-DPAT and R0600,175 increase gliogenesis (NG2-labeled cells). This study provides new insights on the serotonergic regulation of critical phases of neurogenesis helpful to understand the neurogenic and gliogenic effects of antidepressant treatments in different brain regions.

Keywords: Serotonin;, Gliogenesis;, Hippocampus;, Olfactory bulb;, Prefrontal cortex;, Striatum

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0924-977X(09)00258-2

doi:10.1016/j.euroneuro.2009.11.007

European Neuropsychopharmacology
Volume 20, Issue 5 , Pages 336-345, May 2010